Millennium Management LLC Sells 266,668 Shares of Accuray Incorporated (NASDAQ:ARAY)

Millennium Management LLC trimmed its stake in Accuray Incorporated (NASDAQ:ARAY) by 79.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 68,814 shares of the medical equipment provider’s stock after selling 266,668 shares during the quarter. Millennium Management LLC owned approximately 0.07% of Accuray worth $136,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Ameriprise Financial Inc. purchased a new position in shares of Accuray in the fourth quarter worth about $35,000. Prudential Financial Inc. bought a new position in Accuray in the 4th quarter worth approximately $43,000. Susquehanna Fundamental Investments LLC purchased a new position in Accuray in the 4th quarter valued at approximately $66,000. Gabelli Funds LLC raised its holdings in Accuray by 12.5% during the 4th quarter. Gabelli Funds LLC now owns 45,000 shares of the medical equipment provider’s stock valued at $89,000 after acquiring an additional 5,000 shares during the period. Finally, SG Americas Securities LLC raised its holdings in Accuray by 37.4% during the 4th quarter. SG Americas Securities LLC now owns 45,079 shares of the medical equipment provider’s stock valued at $89,000 after acquiring an additional 12,259 shares during the period. 64.08% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded Accuray from a “hold” rating to a “buy” rating in a research report on Friday, May 30th.

Accuray Price Performance

Shares of NASDAQ ARAY opened at $1.25 on Friday. Accuray Incorporated has a 52 week low of $1.14 and a 52 week high of $2.95. The business has a 50-day simple moving average of $1.51 and a two-hundred day simple moving average of $1.86. The company has a quick ratio of 0.88, a current ratio of 1.62 and a debt-to-equity ratio of 3.51. The company has a market cap of $128.77 million, a P/E ratio of -25.00 and a beta of 1.30.

Accuray (NASDAQ:ARAY) last issued its quarterly earnings data on Wednesday, April 30th. The medical equipment provider reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.05) by $0.04. Accuray had a negative net margin of 0.96% and a negative return on equity of 9.75%. The company had revenue of $113.24 million during the quarter, compared to analysts’ expectations of $101.53 million. Research analysts anticipate that Accuray Incorporated will post 0.01 earnings per share for the current fiscal year.

Accuray Company Profile

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.